Loading...
Market
When will University of Houston's fentanyl vaccine receive FDA fast-track designation?
3
Resolution / Starting Odds
Q4 2024 (Oct-Dec) • 25%
Q1 2025 (Jan-Mar) • 25%
Q2 2025 (Apr-Jun) • 25%
Not by end of 2025 • 25%
Official announcement from FDA or University of Houston
Story
University of Houston's Fentanyl Vaccine to Enter Clinical Trials
Sep 2, 2024, 11:28 AM
Researchers at the University of Houston have developed a fentanyl vaccine that is set to enter clinical trials by mid-next year. The vaccine has shown success in animal studies and is designed to prevent the highly addictive opioid from entering the brain, thereby reducing the risk of overdose. This initiative aims to provide a groundbreaking solution to the ongoing opioid crisis.
View original story
Similar markets
Yes • 50%
No • 50%
Granted in 2024 • 25%
Granted in 2025 • 25%
Not granted by 2025 • 25%
Other designation received • 25%
United States • 25%
Europe • 25%
Asia • 25%
Other • 25%
Phase 1 • 25%
Phase 2 • 25%
Phase 3 • 25%
No trial • 25%
Yes • 50%
No • 50%
